Global Medication Market Size, Status and Forecast 2021-2027

投薬の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Medication Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3671
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:134
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、投薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ブランド薬品、ジェネリック薬品)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・投薬の市場動向
・企業の競争状況、市場シェア
・投薬の種類別市場規模(ブランド薬品、ジェネリック薬品)
・投薬の用途別市場規模(病院、クリニック、その他)
・投薬の北米市場規模2016-2027(アメリカ、カナダ)
・投薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・投薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・投薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・投薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、Allergan、Takeda、Boehringer Ingelheim)
・結論

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.

Market Analysis and Insights: Global Medication Market
The global Medication market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Medication market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Medication market.

Global Medication Scope and Market Size
Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Brand Drugs
Generic Drug

Segment by Application
Hospital
Clinic
Other

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Johnson & Johnson
Merck & Co. (MSD)
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medication Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Medication Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Medication Market Perspective (2016-2027)
2.2 Medication Growth Trends by Regions
2.2.1 Medication Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Medication Historic Market Share by Regions (2016-2021)
2.2.3 Medication Forecasted Market Size by Regions (2022-2027)
2.3 Medication Industry Dynamic
2.3.1 Medication Market Trends
2.3.2 Medication Market Drivers
2.3.3 Medication Market Challenges
2.3.4 Medication Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Medication Players by Revenue
3.1.1 Global Top Medication Players by Revenue (2016-2021)
3.1.2 Global Medication Revenue Market Share by Players (2016-2021)
3.2 Global Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Medication Revenue
3.4 Global Medication Market Concentration Ratio
3.4.1 Global Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medication Revenue in 2020
3.5 Medication Key Players Head office and Area Served
3.6 Key Players Medication Product Solution and Service
3.7 Date of Enter into Medication Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Medication Breakdown Data by Type
4.1 Global Medication Historic Market Size by Type (2016-2021)
4.2 Global Medication Forecasted Market Size by Type (2022-2027)

5 Medication Breakdown Data by Application
5.1 Global Medication Historic Market Size by Application (2016-2021)
5.2 Global Medication Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Medication Market Size (2016-2027)
6.2 North America Medication Market Size by Type
6.2.1 North America Medication Market Size by Type (2016-2021)
6.2.2 North America Medication Market Size by Type (2022-2027)
6.2.3 North America Medication Market Size by Type (2016-2027)
6.3 North America Medication Market Size by Application
6.3.1 North America Medication Market Size by Application (2016-2021)
6.3.2 North America Medication Market Size by Application (2022-2027)
6.3.3 North America Medication Market Size by Application (2016-2027)
6.4 North America Medication Market Size by Country
6.4.1 North America Medication Market Size by Country (2016-2021)
6.4.2 North America Medication Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Medication Market Size (2016-2027)
7.2 Europe Medication Market Size by Type
7.2.1 Europe Medication Market Size by Type (2016-2021)
7.2.2 Europe Medication Market Size by Type (2022-2027)
7.2.3 Europe Medication Market Size by Type (2016-2027)
7.3 Europe Medication Market Size by Application
7.3.1 Europe Medication Market Size by Application (2016-2021)
7.3.2 Europe Medication Market Size by Application (2022-2027)
7.3.3 Europe Medication Market Size by Application (2016-2027)
7.4 Europe Medication Market Size by Country
7.4.1 Europe Medication Market Size by Country (2016-2021)
7.4.2 Europe Medication Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Medication Market Size (2016-2027)
8.2 Asia-Pacific Medication Market Size by Type
8.2.1 Asia-Pacific Medication Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Medication Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Medication Market Size by Type (2016-2027)
8.3 Asia-Pacific Medication Market Size by Application
8.3.1 Asia-Pacific Medication Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Medication Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Medication Market Size by Application (2016-2027)
8.4 Asia-Pacific Medication Market Size by Region
8.4.1 Asia-Pacific Medication Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Medication Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Medication Market Size (2016-2027)
9.2 Latin America Medication Market Size by Type
9.2.1 Latin America Medication Market Size by Type (2016-2021)
9.2.2 Latin America Medication Market Size by Type (2022-2027)
9.2.3 Latin America Medication Market Size by Type (2016-2027)
9.3 Latin America Medication Market Size by Application
9.3.1 Latin America Medication Market Size by Application (2016-2021)
9.3.2 Latin America Medication Market Size by Application (2022-2027)
9.3.3 Latin America Medication Market Size by Application (2016-2027)
9.4 Latin America Medication Market Size by Country
9.4.1 Latin America Medication Market Size by Country (2016-2021)
9.4.2 Latin America Medication Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Medication Market Size (2016-2027)
10.2 Middle East & Africa Medication Market Size by Type
10.2.1 Middle East & Africa Medication Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Medication Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Medication Market Size by Type (2016-2027)
10.3 Middle East & Africa Medication Market Size by Application
10.3.1 Middle East & Africa Medication Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Medication Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Medication Market Size by Application (2016-2027)
10.4 Middle East & Africa Medication Market Size by Country
10.4.1 Middle East & Africa Medication Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Medication Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Medication Introduction
11.1.4 Pfizer Revenue in Medication Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Medication Introduction
11.2.4 Roche Revenue in Medication Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Medication Introduction
11.3.4 Sanofi Revenue in Medication Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Medication Introduction
11.4.4 Johnson & Johnson Revenue in Medication Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Details
11.5.2 Merck & Co. (MSD) Business Overview
11.5.3 Merck & Co. (MSD) Medication Introduction
11.5.4 Merck & Co. (MSD) Revenue in Medication Business (2016-2021)
11.5.5 Merck & Co. (MSD) Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Medication Introduction
11.6.4 Novartis Revenue in Medication Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Medication Introduction
11.7.4 AbbVie Revenue in Medication Business (2016-2021)
11.7.5 AbbVie Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Medication Introduction
11.8.4 Gilead Sciences Revenue in Medication Business (2016-2021)
11.8.5 Gilead Sciences Recent Development
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Details
11.9.2 GlaxoSmithKline (GSK) Business Overview
11.9.3 GlaxoSmithKline (GSK) Medication Introduction
11.9.4 GlaxoSmithKline (GSK) Revenue in Medication Business (2016-2021)
11.9.5 GlaxoSmithKline (GSK) Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Medication Introduction
11.10.4 Amgen Revenue in Medication Business (2016-2021)
11.10.5 Amgen Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Medication Introduction
11.11.4 AstraZeneca Revenue in Medication Business (2016-2021)
11.11.5 AstraZeneca Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Medication Introduction
11.12.4 Bristol-Myers Squibb Revenue in Medication Business (2016-2021)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Medication Introduction
11.13.4 Eli Lilly Revenue in Medication Business (2016-2021)
11.13.5 Eli Lilly Recent Development
11.14 Teva
11.14.1 Teva Company Details
11.14.2 Teva Business Overview
11.14.3 Teva Medication Introduction
11.14.4 Teva Revenue in Medication Business (2016-2021)
11.14.5 Teva Recent Development
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Medication Introduction
11.15.4 Bayer Revenue in Medication Business (2016-2021)
11.15.5 Bayer Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Details
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Medication Introduction
11.16.4 Novo Nordisk Revenue in Medication Business (2016-2021)
11.16.5 Novo Nordisk Recent Development
11.17 Allergan
11.17.1 Allergan Company Details
11.17.2 Allergan Business Overview
11.17.3 Allergan Medication Introduction
11.17.4 Allergan Revenue in Medication Business (2016-2021)
11.17.5 Allergan Recent Development
11.18 Takeda
11.18.1 Takeda Company Details
11.18.2 Takeda Business Overview
11.18.3 Takeda Medication Introduction
11.18.4 Takeda Revenue in Medication Business (2016-2021)
11.18.5 Takeda Recent Development
11.18 Boehringer Ingelheim
.1 Boehringer Ingelheim Company Details
.2 Boehringer Ingelheim Business Overview
.3 Boehringer Ingelheim Medication Introduction
.4 Boehringer Ingelheim Revenue in Medication Business (2016-2021)
.5 Boehringer Ingelheim Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Medication Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Brand Drugs
Table 3. Key Players of Generic Drug
Table 4. Global Medication Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Medication Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Medication Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Medication Market Share by Regions (2016-2021)
Table 8. Global Medication Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Medication Market Share by Regions (2022-2027)
Table 10. Medication Market Trends
Table 11. Medication Market Drivers
Table 12. Medication Market Challenges
Table 13. Medication Market Restraints
Table 14. Global Medication Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Medication Market Share by Players (2016-2021)
Table 16. Global Top Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medication as of 2020)
Table 17. Ranking of Global Top Medication Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Medication Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Medication Product Solution and Service
Table 21. Date of Enter into Medication Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Medication Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Medication Revenue Market Share by Type (2016-2021)
Table 25. Global Medication Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Medication Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Medication Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Medication Revenue Market Share by Application (2016-2021)
Table 29. Global Medication Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Medication Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Medication Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Medication Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Medication Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Medication Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Medication Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Medication Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Medication Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Medication Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Medication Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Medication Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Medication Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Medication Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Medication Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Medication Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Medication Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Medication Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Medication Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Medication Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Medication Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Medication Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Medication Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Medication Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Medication Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Medication Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Medication Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Medication Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Medication Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Medication Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Medication Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Medication Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Medication Product
Table 64. Pfizer Revenue in Medication Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Medication Product
Table 69. Roche Revenue in Medication Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Medication Product
Table 74. Sanofi Revenue in Medication Business (2016-2021) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Medication Product
Table 79. Johnson & Johnson Revenue in Medication Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Merck & Co. (MSD) Company Details
Table 82. Merck & Co. (MSD) Business Overview
Table 83. Merck & Co. (MSD) Medication Product
Table 84. Merck & Co. (MSD) Revenue in Medication Business (2016-2021) & (US$ Million)
Table 85. Merck & Co. (MSD) Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Medication Product
Table 89. Novartis Revenue in Medication Business (2016-2021) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. AbbVie Company Details
Table 92. AbbVie Business Overview
Table 93. AbbVie Medication Product
Table 94. AbbVie Revenue in Medication Business (2016-2021) & (US$ Million)
Table 95. AbbVie Recent Development
Table 96. Gilead Sciences Company Details
Table 97. Gilead Sciences Business Overview
Table 98. Gilead Sciences Revenue in Medication Business (2016-2021) & (US$ Million)
Table 99. Gilead Sciences Recent Development
Table 100. GlaxoSmithKline (GSK) Company Details
Table 101. GlaxoSmithKline (GSK) Business Overview
Table 102. GlaxoSmithKline (GSK) Medication Product
Table 103. GlaxoSmithKline (GSK) Revenue in Medication Business (2016-2021) & (US$ Million)
Table 104. GlaxoSmithKline (GSK) Recent Development
Table 105. Amgen Company Details
Table 106. Amgen Business Overview
Table 107. Amgen Medication Product
Table 108. Amgen Revenue in Medication Business (2016-2021) & (US$ Million)
Table 109. Amgen Recent Development
Table 110. AstraZeneca Company Details
Table 111. AstraZeneca Business Overview
Table 112. AstraZeneca Medication Product
Table 113. AstraZeneca Revenue in Medication Business (2016-2021) & (US$ Million)
Table 114. AstraZeneca Recent Development
Table 115. Bristol-Myers Squibb Company Details
Table 116. Bristol-Myers Squibb Business Overview
Table 117. Bristol-Myers Squibb Medication Product
Table 118. Bristol-Myers Squibb Revenue in Medication Business (2016-2021) & (US$ Million)
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Eli Lilly Company Details
Table 121. Eli Lilly Business Overview
Table 122. Eli Lilly Medication Product
Table 123. Eli Lilly Revenue in Medication Business (2016-2021) & (US$ Million)
Table 124. Eli Lilly Recent Development
Table 125. Teva Company Details
Table 126. Teva Business Overview
Table 127. Teva Medication Product
Table 128. Teva Revenue in Medication Business (2016-2021) & (US$ Million)
Table 129. Teva Recent Development
Table 130. Bayer Company Details
Table 131. Bayer Business Overview
Table 132. Bayer Medication Product
Table 133. Bayer Revenue in Medication Business (2016-2021) & (US$ Million)
Table 134. Bayer Recent Development
Table 135. Novo Nordisk Company Details
Table 136. Novo Nordisk Business Overview
Table 137. Novo Nordisk Medication Product
Table 138. Novo Nordisk Revenue in Medication Business (2016-2021) & (US$ Million)
Table 139. Novo Nordisk Recent Development
Table 140. Allergan Company Details
Table 141. Allergan Business Overview
Table 142. Allergan Medication Product
Table 143. Allergan Revenue in Medication Business (2016-2021) & (US$ Million)
Table 144. Allergan Recent Development
Table 145. Takeda Company Details
Table 146. Takeda Business Overview
Table 147. Takeda Medication Product
Table 148. Takeda Revenue in Medication Business (2016-2021) & (US$ Million)
Table 149. Takeda Recent Development
Table 150. Boehringer Ingelheim Company Details
Table 151. Boehringer Ingelheim Business Overview
Table 152. Boehringer Ingelheim Medication Product
Table 153. Boehringer Ingelheim Revenue in Medication Business (2016-2021) & (US$ Million)
Table 154. Boehringer Ingelheim Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medication Market Share by Type: 2020 VS 2027
Figure 2. Brand Drugs Features
Figure 3. Generic Drug Features
Figure 4. Global Medication Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Medication Report Years Considered
Figure 9. Global Medication Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Medication Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Medication Market Share by Regions: 2020 VS 2027
Figure 12. Global Medication Market Share by Regions (2022-2027)
Figure 13. Global Medication Market Share by Players in 2020
Figure 14. Global Top Medication Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medication as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Medication Revenue in 2020
Figure 16. Global Medication Revenue Market Share by Type (2016-2021)
Figure 17. Global Medication Revenue Market Share by Type (2022-2027)
Figure 18. North America Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Medication Market Share by Type (2016-2027)
Figure 20. North America Medication Market Share by Application (2016-2027)
Figure 21. North America Medication Market Share by Country (2016-2027)
Figure 22. United States Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Medication Market Share by Type (2016-2027)
Figure 26. Europe Medication Market Share by Application (2016-2027)
Figure 27. Europe Medication Market Share by Country (2016-2027)
Figure 28. Germany Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Medication Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Medication Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Medication Market Share by Region (2016-2027)
Figure 38. China Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Medication Market Share by Type (2016-2027)
Figure 46. Latin America Medication Market Share by Application (2016-2027)
Figure 47. Latin America Medication Market Share by Country (2016-2027)
Figure 48. Mexico Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Medication Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Medication Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Medication Market Share by Country (2016-2027)
Figure 54. Turkey Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Medication Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Medication Business (2016-2021)
Figure 58. Roche Revenue Growth Rate in Medication Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Medication Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Medication Business (2016-2021)
Figure 61. Merck & Co. (MSD) Revenue Growth Rate in Medication Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Medication Business (2016-2021)
Figure 63. AbbVie Revenue Growth Rate in Medication Business (2016-2021)
Figure 64. Gilead Sciences Revenue Growth Rate in Medication Business (2016-2021)
Figure 65. GlaxoSmithKline (GSK) Revenue Growth Rate in Medication Business (2016-2021)
Figure 66. Amgen Revenue Growth Rate in Medication Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Medication Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Medication Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Medication Business (2016-2021)
Figure 70. Teva Revenue Growth Rate in Medication Business (2016-2021)
Figure 71. Bayer Revenue Growth Rate in Medication Business (2016-2021)
Figure 72. Novo Nordisk Revenue Growth Rate in Medication Business (2016-2021)
Figure 73. Allergan Revenue Growth Rate in Medication Business (2016-2021)
Figure 74. Takeda Revenue Growth Rate in Medication Business (2016-2021)
Figure 75. Boehringer Ingelheim Revenue Growth Rate in Medication Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[投薬の世界市場規模・現状・予測2021年-2027年] (Global Medication Market Size, Status and Forecast 2021-2027 / QY21APR3671)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆